Stayble Therapeutics AB Sustainability Reports
Stayble Therapeutics AB is a clinical-stage pharmaceutical company that develops injection-based treatments for disc herniation and chronic low back pain.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300WD23DE1US21868
FIGI: BBG00DZRV3L9
6 reports from 2019 to 2024